Exosens Statistics
Total Valuation
Exosens has a market cap or net worth of EUR 2.08 billion. The enterprise value is 2.22 billion.
Market Cap | 2.08B |
Enterprise Value | 2.22B |
Important Dates
The last earnings date was Wednesday, July 30, 2025.
Earnings Date | Jul 30, 2025 |
Ex-Dividend Date | May 28, 2025 |
Share Statistics
Current Share Class | 50.77M |
Shares Outstanding | n/a |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 29.79M |
Valuation Ratios
The trailing PE ratio is 41.10 and the forward PE ratio is 24.78.
PE Ratio | 41.10 |
Forward PE | 24.78 |
PS Ratio | 4.81 |
PB Ratio | 4.83 |
P/TBV Ratio | n/a |
P/FCF Ratio | 36.63 |
P/OCF Ratio | 20.53 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.69, with an EV/FCF ratio of 39.17.
EV / Earnings | 43.95 |
EV / Sales | 5.15 |
EV / EBITDA | 18.69 |
EV / EBIT | 23.93 |
EV / FCF | 39.17 |
Financial Position
The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.62.
Current Ratio | 2.51 |
Quick Ratio | 1.67 |
Debt / Equity | 0.62 |
Debt / EBITDA | 2.26 |
Debt / FCF | 4.73 |
Interest Coverage | 5.08 |
Financial Efficiency
Return on equity (ROE) is 13.72% and return on invested capital (ROIC) is 8.65%.
Return on Equity (ROE) | 13.72% |
Return on Assets (ROA) | 7.02% |
Return on Invested Capital (ROIC) | 8.65% |
Return on Capital Employed (ROCE) | 12.50% |
Revenue Per Employee | 227,198 |
Profits Per Employee | 26,595 |
Employee Count | 1,401 |
Asset Turnover | 0.52 |
Inventory Turnover | 1.72 |
Taxes
In the past 12 months, Exosens has paid 19.53 million in taxes.
Income Tax | 19.53M |
Effective Tax Rate | 25.97% |
Stock Price Statistics
The stock price has increased by +78.29% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +78.29% |
50-Day Moving Average | 40.98 |
200-Day Moving Average | 29.31 |
Relative Strength Index (RSI) | 54.02 |
Average Volume (20 Days) | 163 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Exosens had revenue of EUR 431.68 million and earned 50.53 million in profits.
Revenue | 431.68M |
Gross Profit | 259.04M |
Operating Income | 92.81M |
Pretax Income | 75.21M |
Net Income | 50.53M |
EBITDA | 115.20M |
EBIT | 92.81M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 124.00 million in cash and 268.40 million in debt, giving a net cash position of -144.40 million.
Cash & Cash Equivalents | 124.00M |
Total Debt | 268.40M |
Net Cash | -144.40M |
Net Cash Per Share | n/a |
Equity (Book Value) | 429.50M |
Book Value Per Share | n/a |
Working Capital | 189.00M |
Cash Flow
In the last 12 months, operating cash flow was 101.15 million and capital expenditures -44.46 million, giving a free cash flow of 56.70 million.
Operating Cash Flow | 101.15M |
Capital Expenditures | -44.46M |
Free Cash Flow | 56.70M |
FCF Per Share | n/a |
Margins
Gross margin is 60.01%, with operating and profit margins of 21.50% and 12.90%.
Gross Margin | 60.01% |
Operating Margin | 21.50% |
Pretax Margin | 17.42% |
Profit Margin | 12.90% |
EBITDA Margin | 26.69% |
EBIT Margin | 21.50% |
FCF Margin | 13.13% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.27%.
Dividend Per Share | 0.10 |
Dividend Yield | 0.27% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 9.16% |
Buyback Yield | n/a |
Shareholder Yield | 0.27% |
Earnings Yield | 2.43% |
FCF Yield | 2.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 6 |